Therapy with substance
Novamind is building the infrastructure required for a regulated psychedelics industry
Why psychedelics?
“Psychedelics, used responsibly and with proper caution, would be for psychiatry what the microscope is for biology or the telescope is for astronomy.”
— Stanislav Grof, MD
At the forefront of mental healthcare innovation
We are dedicated to advancing psychedelic research and catalyzing personal wellness.
Read about usOur missionTo facilitate safe, legal access to psychedelics.
Our visionA new standard of mental healthcare.
Press releases
February 23, 2021
Novamind to Present at Benzinga Conference
February 22, 2021
Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF
February 19, 2021
Novamind Announces Symbol Change on OTC Market To “NVMDF”
February 11, 2021
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
